Discussion to: Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non–small cell lung cancer
The Journal of Thoracic and Cardiovascular Surgery · 2024
DOI: 10.1016/j.jtcvs.2023.10.035 ↗Kurz gefasst
Kommentar in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Staging, Pneumonectomy.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
(2024). Discussion to: Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2023.10.035
Vancouver
Discussion to: Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. 2024. doi:10.1016/j.jtcvs.2023.10.035
BibTeX
@article{euvimed2024,
title = {Discussion to: Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non–small cell lung cancer},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2024},
doi = {10.1016/j.jtcvs.2023.10.035}
}
EUVIMED